Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety, tolerability, efficacy, and
pharmacokinetics of adjunctive therapy of LP352 in adults with developmental and epileptic
encephalopathies.